PneumRx
A medical device company focused on developing minimally-invasive solutions for unmet medical needs in pulmonary medicine.
Launch date
Market cap
-
Enterprise valuation
$475m (Public information from Dec 2014)
Marlborough Massachusetts (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
N/A | $2.4m | Series A | |
$10.7m | Series A | ||
$27.0m | Series B | ||
$33.0m | Late VC | ||
$475m Valuation: $475m | Acquisition | ||
Total Funding | $73.1m |
Related Content
Recent News about PneumRx
EditInvestments analysisEdit
Investments by PneumRx
EditACQUISITION by Boston Scientific Mar 2018
exited
exited
ACQUISITION by Shockwave Medical Jan 2023
exited